139 related articles for article (PubMed ID: 11733091)
1. N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers for targeted delivery of 8-aminoquinoline antileishmanial drugs.
Nan A; Nanayakkara NP; Walker LA; Yardley V; Croft SL; Ghandehari H
J Control Release; 2001 Dec; 77(3):233-43. PubMed ID: 11733091
[TBL] [Abstract][Full Text] [Related]
2. Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis.
Nan A; Croft SL; Yardley V; Ghandehari H
J Control Release; 2004 Jan; 94(1):115-27. PubMed ID: 14684276
[TBL] [Abstract][Full Text] [Related]
3. N-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents.
Nicoletti S; Seifert K; Gilbert IH
Int J Antimicrob Agents; 2009 May; 33(5):441-8. PubMed ID: 19097763
[TBL] [Abstract][Full Text] [Related]
4. Water-soluble polymer-drug conjugates for combination chemotherapy against visceral leishmaniasis.
Nicoletti S; Seifert K; Gilbert IH
Bioorg Med Chem; 2010 Apr; 18(7):2559-65. PubMed ID: 20338769
[TBL] [Abstract][Full Text] [Related]
5. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
[TBL] [Abstract][Full Text] [Related]
6. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics.
Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R
J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676
[TBL] [Abstract][Full Text] [Related]
7. Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells.
Tijerina M; Kopecková P; Kopecek J
Pharm Res; 2003 May; 20(5):728-37. PubMed ID: 12751627
[TBL] [Abstract][Full Text] [Related]
8. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
Line BR; Mitra A; Nan A; Ghandehari H
J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
[TBL] [Abstract][Full Text] [Related]
9. Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation.
Gupta PK; Jaiswal AK; Kumar V; Verma A; Dwivedi P; Dube A; Mishra PR
Mol Pharm; 2014 Mar; 11(3):951-63. PubMed ID: 24495144
[TBL] [Abstract][Full Text] [Related]
10. Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
Borgman MP; Ray A; Kolhatkar RB; Sausville EA; Burger AM; Ghandehari H
Pharm Res; 2009 Jun; 26(6):1407-18. PubMed ID: 19225872
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates.
Luo Y; Bernshaw NJ; Lu ZR; Kopecek J; Prestwich GD
Pharm Res; 2002 Apr; 19(4):396-402. PubMed ID: 12033370
[TBL] [Abstract][Full Text] [Related]
12. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
Duncan R; Kopecková-Rejmanová P; Strohalm J; Hume I; Cable HC; Pohl J; Lloyd JB; Kopecek J
Br J Cancer; 1987 Feb; 55(2):165-74. PubMed ID: 3468994
[TBL] [Abstract][Full Text] [Related]
13. Analogues of 8-[[6-(diethylamino) hexyl]amino]-6-methoxy-4-methylquinoline as candidate antileishmanial agents.
LaMontagne MP; Dagli D; Khan MS; Blumbergs P
J Med Chem; 1980 Sep; 23(9):981-5. PubMed ID: 7411553
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
15. Experimental chemotherapy with Allium sativum (Liliaceae) methanolic extract in rodents infected with Leishmania major and Leishmania donovani.
Wabwoba BW; Anjili CO; Ngeiywa MM; Ngure PK; Kigondu EM; Ingonga J; Makwali J
J Vector Borne Dis; 2010 Sep; 47(3):160-7. PubMed ID: 20834086
[TBL] [Abstract][Full Text] [Related]
16. Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo.
Sinha J; Mukhopadhyay S; Das N; Basu MK
Drug Deliv; 2000; 7(4):209-13. PubMed ID: 11195427
[TBL] [Abstract][Full Text] [Related]
17. High-molecular weight HPMA copolymer-adriamycin conjugates.
Dvorák M; Kopecková P; Kopecek J
J Control Release; 1999 Aug; 60(2-3):321-32. PubMed ID: 10425337
[TBL] [Abstract][Full Text] [Related]
18. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.
Lu ZR
Adv Drug Deliv Rev; 2010 Feb; 62(2):246-57. PubMed ID: 20060431
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed Macrophage Mannose Receptor Targeted Nanocapsules- Mediated Cargo Delivery Approach for Eradication of Resident Parasite: In Vitro and In Vivo Studies.
Asthana S; Gupta PK; Jaiswal AK; Dube A; Chourasia MK
Pharm Res; 2015 Aug; 32(8):2663-77. PubMed ID: 25715698
[TBL] [Abstract][Full Text] [Related]
20. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
